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This chapter introduces the matrix approach as a method of studying the life 
sciences. It builds on insights from the philosophy and sociology of science over 
the past decades against which it is laid out. The contribution of this new approach 
is that it reconfigures the life sciences as multidisciplinary and multi-institutional 
societal projects. The case study of stem cell research shows that one cannot 
separate internal and external, that is epistemic, social, ethical, and political factors 
affecting the development of a life science. The matrix approach allows for the 
examination of this complex and dynamic web of interests and societal practices 
and highlights the important role of legal, normative, technical and political 
conditions and activities in making the science work in specific ways. Life 
sciences operate in a matrix of diverse societal intersections and spheres of 
dominance. The approach especially reframes the role and scope of the humanities 
and social sciences. It prepares the ground for a self-critical reflection in bioethics, 
social sciences, and philosophy. These disciplines do not just analyse stem cell 
research as an object, from a distance, they co-configure it and shape its 












The matrix approach is a new method for investigating the developing life sciences in the 
context of societal demands and practices. It configures the social practices and 
institutions that engage with the life sciences as constitutive factors and parts of said 
development. The matrix approach builds on theories in the philosophy, history and 
sociology of science, and aims to enhance critical self-reflexivity in the life sciences as 
well as in the social sciences and humanities. The case study is stem cell research, which 
was developed from the early 2000s and is entangled with more and more social and 
institutional contexts as well as academic arenas.  
 
 
After some situating remarks, we begin to discuss the matrix approach by first 
distinguishing it from the conventional narrations of the breakthrough myth in science 
journals and institutions. We then discuss how the history of science has increasingly 
included socio-political and normative dimensions into its analyses of how science 
advances, changes, and the reasons for this – pointing out that the normative ethical 
dimension is still being under-represented in concrete science studies. We then question 
whether stem cell science can be understood as a unified field due to the obscure object 
that lends it its name, or due to the aim of advancing new clinical treatments that is 
supposedly shared by the partaking life science disciplines. The literature has shown it to 
be the case that, and why, these perspectives are falling short, and the matrix approach 
offers the alternative of a situated approach to life sciences in and as social practice. The 
chapter closes with a brief overview of the segments in the stem cell matrix which the 





2) The Matrix Approach 
 
Our method is based on problematization. Problematization means putting the issue in 
problem form and identifying it as a problem for politics (cf. Foucault, 1997, 114). It 
follows Paul Rabinow, who suggested not to take descriptions of a current ‘situation as 
given’ (cf. Rabinow, 2003, 15ff.), referring to Michel Foucault’s suggestion to examine 
discourses using multiple methods and perspectives. Critical normative interactions with 
stem cell research, undertaken in philosophical epistemology and ethics as well as in 
empirical Science and Technology Studies (STS), ask and give accounts of both the 
problematizations that inform which ‘facts’ about a science are presumed as given and 
not spelled out or questioned, as well as focussing the analysis on the power relations in 
and around stem cell research. 
 
 
Terminologically, we chose the matrix term not least as a nod to Thomas Kuhn’s 
‘disciplinary matrix’, defined in the postscript to The Structure of Scientific Revolutions 
as: ‘the entire constellation of beliefs, values, techniques, and so on shared by the 
members of a given community’ (Kuhn, 2012, 174). Like Kuhn, we explore the 
constitutional conditions for the development, contents, and constellations of science. 
But we move beyond looking at science as if it developed largely ‘insulated’ from 
society (Kuhn, 2012, 163). We widen the term to include analyses of the power relations, 
with the socio-economic, political, cultural, and epistemic dynamics and forces in stem 
cell research discourses and practices.  
 
 
Political governance, funding policies, and organizations of research are comparatively 
transparent societal conditions shaping science. Furthermore, public funding arguably 
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entails a responsibility put upon science with the aim of benefitting the public good (e.g. 
European Commission, 2009). The social, economic, and intellectual conditions of 
science are, we propose, not additions on top of the ‘real’ intra-scientific developments. 
They are an integral part of scientific development. In stem cell research this is 
particularly readily apparent, given the public debates about the ethical acceptability of 
hESC (human embryonic stem cell) research still in force in many countries, and the 
legal and regulatory limitations established to restrict conduct of stem cell clinical trials 
(Hauskeller, 2017).  
 
 
Insights articulated in the philosophy and sociology of science followed and expanded on 
Kuhn, such as the Mode 2 concept by Helga Nowotny and colleagues. Mode 2 
conceptualizes science as inextricably interwoven with past and current social practices 
as well as future plans and expectations, as a complex collaborative endeavour that 
generates knowledge in the context of application. ‘Science could no longer be 
demarcated from the “others” of society, culture and more arguably economy’ (Nowotny 
et al., 2001, 1). Including these dimensions in the study of a science better captures the 
dynamics we want to highlight, opening up reflective and constructive studies of life 
science developments. What is missing is a similar inclusivity and subjection of the 
social sciences and humanities to said analysis of, for example, stem cell research.  
 
 
The common metaphor ‘field’ as used widely in the history and philosophy of science, 
suggests that a research area can be identified through reference to its object or method. 
The field metaphor suggests that a distinguishable science develops in a logic of its own, 
driven largely by immanent factors and with definable boundaries. Yet, the conduct of 
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research is cross-sectional in and between the life sciences, humanities, and social 
sciences, not confining itself to integrate into a neat order.  
 
 
Stem cell science represents itself as unified by the object from which it gets its name: 
stem cells. Stem cells, however, embody an obscure and transient empirical object. Plus, 
stem cell research has commonalities with many other life sciences in its methods and 
social embeddedness. Concerning its methods, stem cell research is not a distinct ‘field’ 
but a cross-section relating to various disciplines with shared routines and knowledge.  
Conflicting and mutually re-enforcing engagements between many pre-existing or 
accompanying developments in social and scientific practices and institutions are often 
not reflected in the narratives scientists and journals use to explain science. We 
problematize the marginalization of these influences in order to portray stem cell 
research as shaped in and by the socio-political and ethical conflicts in society.  
 
 
The matrix does not require the notion of a field or similar metaphors. It emphasizes that 
disciplines, institutions, practices, and interests that contribute to the life sciences are 
shared across life science specialisms. For example, particular applications as well as 
moral norms and laws apply to genetics, reproductive medicine and stem cell research, 
which among one another exchange materials and build on one another’s laboratory 
techniques and objects. The matrix is a discontinuous, multi-institutional and multi-
disciplinary space of knowledges, interests, norms, and practices. Social, economic, and 
other conditions are not weighted as secondary to developments in the laboratory and 
clinic. They are inextricably part of the stem cell science and its objectives, as elements 
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of its matrix. Ethics and philosophy, historical narratives and journalistic accounts, too, 
are constitutive and representative parts of stem cell science – they are not external to it.  
 
 
A comprehensive whole of stem cell research cannot be captured because of these open 
boundaries and the many connections to other practices. The matrix approach opens up 
and includes interconnecting partial perspectives that can be held to account for their 
viewpoint and methods. They contribute situated knowledges (Haraway, 1988) to the 
stem cell discourse, for empirically informed and conceptually reflective ethics and 
philosophy of science. 
 
 
The advantage of the matrix approach is that it can conceptualize the epistemic 
convergence and divergence that characterize recent life sciences (Andersen, 2016). It 
can recognize and attend to the tensions between plural norms and values in the moral, 
epistemological, and economic sense (cf. Rajan, 2006; Gottweis, Salter and Waldby, 
2009). In the matrix we find multiple and changing loci of power and gravity. It is in 
flux, a multi-intersectional web of ways of knowing, doing, laboratory and governance 
technologies, and modes of evaluation. 
 
 
The understanding of a problem affects and is affected by normative debates about 
different kinds of values enmeshed in it. If the object, in this case the stem cell, is itself 
overdetermined with conflicting value judgments and contentious in society, then 
commentary and judgement cannot style themselves as from the outside or the margins. 
Ethicists, too, often take positions implicitly, when and through choosing what they 
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accept to be facts and decide to emphasize, thus privileging one perspective over others. 
Because the social science, humanities, and media debates also influence the perception 
and understanding of stem cell research in wider society and even to some extent in 
science itself, it matters that they are critically aware and reflective in their interactions 
and judgements. In the matrix, normativity and ethics enter at different points and in 
diverse ways that normative ethics especially must reflect, in view of its own role. An 
examination of the multiple factors shaping the development of stem cell research also 
has a heuristic function for ethics. Many ethical issues in the broadest sense fall into the 
chasm between different disciplines and tend to be overlooked by common bioethical 
approaches. Moral norms and values, often implicit in acts that seem not to discuss 
normativities beyond those directly at stake, reach further and actually build on a whole 
set of societal premises and conditions as well as material conditions for scientific 
practice. Complex implicit and explicit values that create conditions for laboratory 
research or legal discourse, for example, are mobilized and weighted. If certain forms of 
stem cell research cannot actually come into the clinic via the approved channels of 
scientific medicine because regulatory hurdles and conditions have aligned to form major 
obstacles, then research pathways dry up –, whilst the unproven use flourishes in private 
hospitals (Tanner et al., in this volume; Hauskeller, 2018).  
 
 
Building on critiques of bioethics (Haimes, 2002; Hedgecoe, 2004; De Vries et al., 
2007), the matrix approach provides a reflexive framework for responsible ethical and 
normative examinations of the life sciences. It can also encompass analyses of their roles 
in societal power and knowledge dynamics. To advance ethical reflection that can keep 
pace with the complexity of the tasks, the ethics within and relating to stem cell and 
adjacent research needs to be considered also in the context of the socioeconomic 
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In what follows we first discuss different ways of representing stem cell science in 
different disciplines and discourses and examine the implications of these representations 
for the ongoing critical discussions and ethical reflections. This section develops the 
matrix perspective by drawing out how it differs from existing approaches of making 
sense of stem cell research. In step two, we explain briefly how this perspective is 
illustrated across the book chapters, most of which report findings from analyses of 




The chapters in this volume present different aspects within the matrix, some accepting 
or challenging directly the conventional definition of stem cell research as a field, others 
studying how the practices employed and produced in this research are adopted, 
reflected, and used by different professional or academic groups such as lawyers, 
theologians, patients, or economists. In the matrix of diverse, intersecting elements, 
biology and medicine are prominent, but they do not feature as the mutually 
interdependent but epistemically and socially independent producers of the gestalt and 
trajectory of the research and its uses. What we hope to show is that the conditions in and 
responses from different parts of society to that research have become constituent parts 
of its specific configurations and practices in different research projects, different 
laboratories and clinics, and in different countries. We believe that this characterizes the 
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3) Different Approaches to Conceptualizing the Life Sciences  
 
 
In what follows we discuss why the matrix approach rejects forms of understanding and 
the presentation of stem cell research in idealized, simplistic ways, especially in what we 
call origin narratives – and how the approach builds on and integrates insights from 




3.1) ‘Breakthrough’ myths 
 
A conventional narrative about stem cell research, widely found in articles, text books, 
and online (Vogel, 1999) goes something like this: stem cell research emerged as a 
distinct domain of bio- and medical science triggered by a scientific ‘breakthrough’. 
Usually this past event is marked with reference to a pair of articles reporting the 
cultivation of human stem cell lines in the laboratory (Thomson et al., 1998; Shamblott et 
al., 1998). The new kind of cell lines, a contemporary research object in the laboratory 
derived from early embryos in vitro using refined cell culture techniques, attracted 
researchers in different existing specialisms, who began to work on such human cell 
lines. Diverse research agendas and specialisms regrouped and rearticulated their aims 
and methods increasingly using the new denominator stem cell research. Twenty years 
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after the first cultivation of hESC lines, stem cell research is a fast-paced field with a 
large economic turnover and, in some countries, big private markets for stem cell 
treatments that do not conform to established standards of safety and efficacy (Petersen 
et al., 2017). Of the many cell therapies envisioned, only a few have been licensed, 
although numerous are at different stages of clinical trial (Trounson and DeWitt, 2016). 
A range of new techniques and biological insights into the properties of cells and tissues 
in vitro has been created, informing regenerative medicine but also reproductive and 
organ transplantation medicine (Hauskeller and Weber, 2011; Zenke, Marx-Stölting and 
Schickl, 2018).  
 
 
Such a narrative selects, orders, and interprets one or several origin events to create a 
coherent birth story for a new endeavour in the sciences. It suggests progress, major 
successes owed to identifiable specific discoveries, and reaffirms the importance of that 
new ‘field’. It also firmly places the evolution of this ‘field’ as an inherent part of the 
dynamics within science – as a product of science.  
 
 
Scientific practices and foci are in flux. Elements and techniques overlap and researchers 
transition from one into another (Powell et al., 2007). Objects and technologies as well as 
physical infrastructure and laboratory space are often shared. One research project can be 
framed as a contribution to several fields, for example, establishing markers for 
hematopoietic properties can be achieved through genomics, stem cell or cancer research. 
These metaphoric ‘fields’ are not separated by hedges nor is ownership registered. 
Between the zones of overlap, crossover and similar interests, there is also competition. 
A team may apply for research funding from different dedicated streams and results may 
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be published in a range of specialist journals with different aspects of the method and 
findings highlighted. Specialisms emerge and regroup, coalescing around new concepts 
or practices. This fluidity allows the regular celebration of advances and ‘breakthroughs’, 
which in turn feeds the expectation that the life sciences are moving forward. Reasons to 
produce such rationales – apart from self-celebration and reaffirmation of status – are 
pragmatic, especially in light of the pressures to defend contested research in public and 
attract the required large amounts of public and private research sponsorship.  
 
 
The breakthrough narrative is ideological more than explanatory. It creates the myth of 
both the extraordinary scientist and dramatic immanent change. The long term labour 
across many laboratories and teams upon which ‘breakthroughs’ rest, as well as the 
societal contexts that shape science in practice, are not taken into account. Kuhn (1962) 
and Foucault (1970) have, in different ways, analysed broader conceptual shifts in how 
science operates, such as paradigm changes, or the order of things it studies. Ludwik 
Fleck has illustrated how power and community relations among teams affect what 
counts as proper science (Fleck, 1935). In each of these classic works science is a social 
enterprise, in which individuals who apply unconventional perspectives with 
inconvenient implications, if accepted, tend to be ignored or marginalized rather than 
awarded laurels, at least for a while. The narration of origin events creating stem cell 
research in particular has been criticized in the history, and social studies, of science 
(Geesink, Prainsack and Franklin, 2008). The matrix approach builds on these critiques – 
moreover though, it problematizes the idea that science is driven, if not solely then 
mostly, by science per se (cf. Collins and Pinch, 1998). We develop these points in the 





3.2) Expanding multi-strand history narratives  
 
History of science studies often situate the different disciplinary and knowledge elements 
of a contemporary ‘field’ and explore their genealogy. For example, an overview on the 
notion of stem cell in a science journal concludes,  
 
[in] summary, the early uses of the term stem cell were made in the late 19th 
century in the context of fundamental questions in embryology: the 
continuity of the germ-plasm and the origin of the blood system. The 
demonstration of the existence of hematopoietic stem cells … established 
these cells as the prototypical stem cells: cells capable of proliferating nearly 
indefinitely (self-renewal) and of giving rise to specialized cells 
(differentiation). 
(Ramalho-Santos and Willenbring, 2007, 37) 
 
It highlights the point that stem cell research absorbs different strands of nineteenth and 
twentieth century biological and medical research, depending on whether the word, the 
concept, or the laboratory identification of such cells are foregrounded. There is not one 
grand discovery. The single breakthrough from 1998 appears as just one of many 
elements in a complex research landscape.  
 
 
Taking into account histories not of a particular disease or cell type but multi-disciplinary 
genealogies contributing to stem cell research, the historical analyses show that no single 
definitive origin or founding event can be identified. Whereas the name and idea of a 
stem cell had been around since the late nineteenth century, the laboratory creation of the 
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first embryonic stem cell lines, from mice, happened in 1981 and has been credited to 
two British teams (Evans and Kauffmann, 1981; Martin, 1981). In 2007, after hESC lines 
had been created, the prominent Nobel Committee recognized the importance of this 
earlier work with an award for Martin Evans (Nobel Committee, 2007). Although it 
undermines birth event myths, the common type of account that lists a chain of 
individual discoveries and discoverers usually pays insufficient attention to extra-
scientific events and conditions that drive and shape science.  
 
 
Broader analyses have been provided by historians of science and medicine on individual 
elements such as the histories of embryology, genetics and heredity, or cancer research. 
Research into first heredity, then conceptually narrowed down to genetics, now wider 
again in the concept of genomics in tandem with cell biology and embryology, are all 
very prominent in stem cell research and highlight the latter’s close entwinement with the 
former. Further historical studies of basic and applied research draw out a web of 
contributing knowledge practices that cover both epistemological and political quests, for 
example in Helga Satzinger’s analysis of the role of political ideologies, racism, and 
sexism in the status and promotion of different concepts informing genetics and hormone 
research (2014). Concerning stem cell research directly, Beatrix Rubin (2008) and 
Holger Maehle (2011) among others, examined it in relation to radiation and cancer 
research. Understanding the response of the human organism to radiation and its often 
deadly effects became politically imperative from the first half of the twentieth century 
onwards. Scientific experimentation, medical use, and especially the use of atomic 
bombs created an imperative to find ways of helping those affected or at risk. From the 
1950s, medical research with cultures of stem cells from bone marrow and tumours 
began to find ways of offsetting radiation damage, incubating the development of 
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radiotherapy combined with the reconstitution of their blood and immune systems for 
some cancers (Rubin, 2008; Maehle, 2011).  
 
 
The matrix approach differs from history of science narratives in its emphasis on the 
mutual interdependence and influence of diverse and contradictory societal and scientific 
developments in addition to multi-strand and non-linear scientific and political events 
changing sciencescapes. Stem cell research as a ‘field’ was politically and socially 
promoted, albeit as a fusion of diverse disciplinary techniques and concepts around an 
object within the sciences. Its contemporary gestalt has been influenced by decisions and 
events since the late 2000s. Those include choices and directed collaborations across 
political, social and commercial sectors, in the hope that this focus and coalescence of 
biomedical sciences would deliver societal benefits, a viewpoint expressed for instance 
in UK policy papers in the early 2000s (Hauskeller, 2004). The 1998 ‘breakthrough’ may 
represent both the technical fine-tuning of methods of cultivating and altering embryonic 
cells, as well as a convenient rhetorical vantage point to make a new ‘field’. 
Terminologically, however, it seems that instead of disciplines (biology, medicine), 
institutions (clinic, laboratory), or techniques (radiation, transfusion and cell 
transplantation, developmental microbiology), the object was chosen as identifier: the 
(human embryonic) stem cell. The myth of the field formation around an object is 
established in the naming routines in medicine, e.g. cardiology, embryology or 
haematology, and has been adopted in the life sciences. Also in stem cell research, an 
object-based denominator has gained recognition and traction in academic and public 
discourses, so that historians, philosophers, and ethicists rarely critique the suggested 





3.3) Why ‘stem cells’ are not field-forming objects 
 
What stem cells are is a controversial subject among philosophers and stem cell 
scientists alike. The special characteristics of a stem cell as commonly defined by 
scientists, are a high proliferation rate and the capacity to divide into both cells such as 
itself and more differentiated daughter cells. But whether such are the properties of 
special cells that are naturally and continually present, often dormant, in the organism – 
or whether they are states of cells that many cells can potentially enter into and leave 
again – is matter of a long-standing controversy. Put differently, stem cell capacities may 
be intrinsic features of identifiable cells or rather a transient feature of many cells, a way 
of being adopted in response to conditions in the cell environment. How stem cells are 
conceptualized has implications for the feasibility of advancing therapeutic strategies, as 
has recently been discussed by Lucy Laplane (2016) with the example of cancer stem 
cells. She demonstrates a spectrum of possible metaphysical background assumptions 
and the relevance of clarifying these assumptions for therapeutic application. For now, 
consensus and clarity about stem cell concepts are lacking not only on the ontological 
level. The empirical concepts implicitly or explicitly guiding practitioners’ identification 




The huge variety of different stem cell types in different species, developmental stages, 
tissues and cell cultures, raises the issue of clear and unambiguous criteria for 
distinguishing stem cells from other cell types. So far, at least, specific features 
measurable in all but only stem cells have not been proved experimentally. Three 
 
16 
attempts at identifying a common molecular signature of stem cells in the early 2000s 
failed (cf. Laplane, 2016, 115–20). This lack of a reliable characteristic of stem cells 
could have consequences for the unity of the ‘field’ of research: ‘[w]ithout a general 
“signature” of traits shared by stem cells across different environments, the field of stem 
cell biology seems fragmented, unified only by a common label for disparate objects of 
study’ (Fagan, 2013, 7).  
 
 
Melinda Fagan argues that shared among stem cell researchers are the basic experimental 
steps of extracting cells from an organismal source and determining their properties, but 
that knowledge about stem cells is always bound to specific experimental designs and 
refers not to any ‘natural stem cell’ but to artificial entities in specific laboratory contexts 
(Fagan, 2013, 68). This ‘experimental relativity’ (Fagan, in this volume) implies that 
extrapolation of experimental results is problematic and that the influence of the cell 
culture conditions on the measured features of cells is indeterminable: ‘the investigation 
might be forcing the stem-cell phenotype on the population being studied’ (Zipori, 2004, 
876). Other epistemic problems arise from the stem cell concept itself and the basic 
structure of stem cell experiments such as the ‘evidential gap between experimental data 
and hypotheses about stem cell capacities’ (Fagan, in this volume).  
 
 
Far from providing an empirical and unambiguous basis for the formation of a new 
research field, thus far ‘stem cell’ is a messy concept referring to not-well-defined 
objects with fuzzy boundaries. That which is available is only a patchwork of highly 
context-specific knowledge about different groups of cells that are mostly research and 
laboratory artefacts. The matrix approach is distinct from many traditional forms of 
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social studies of science that ‘tended toward the dissolution of all distinctive boundaries 
demarcating the sciences’ (Keller, 1992, 3). In accordance with Evelyn Keller’s ‘middle-
of-the-road-position’ (ibid.), regarding stem cell research as a social practice does not 
mean that inner-scientific dynamics and epistemic commitments do not merit close 
scrutiny. The models and explanatory standards accepted within a research community, 
as well as technological and further conditions that shape the course of science are part of 
matrix studies. History and philosophy of science are traditionally bound to historical 
biographies of scientific objects (Arabatzis, 2006) and to models and techniques (Chang, 
2007) or research groups (Kohler, 1994). Rita Temmerman has demonstrated how 
terminological conventions bury multi-layered intersections of conceptualization, also in 
the life sciences (Temmerman, 2000, 103). Moreover, Ann-Sophie Barwich has argued 
that once philosophy and history of science look at the latter as a complex of changing 
material practices, instruments, discourses, etc., an extension is needed of the meaning of 
terminology that refers to concepts, models, objects, and discourses in the sciences 
(Barwich, 2013). The matrix approach addresses these shortcomings, integrating 
technical and conceptual details as analysed by Fagan and Laplane, with knowledge of 
the web of social, political, economic, and ideological factors and institutions. 
 
 
3.4. Why methods and clinical goals do not distinguish a stem cell ‘field’  
 
 
Notwithstanding the outlined epistemological problems, the stem cell lends a name to a 
diverse and sprawling multitude of research endeavours. The spread of scientific 
pathways taken, and the researchers involved, is evidenced by the dedicated science 





The established organization of science into distinct disciplines and specializations, each 
with its specific viewpoint, communities, and institutional infrastructures is modelled 
around objects and technologies. In this logic it seems reasonable to assume that a new 
kind of object and affiliated set of technologies can disrupt this order, bringing forth a 
new field that draws on and pulls in expertise as well as infrastructures across several 
fields of research. The researchers working on stem cells in evolutionary and 
developmental biology, in oncology, haematology, cell biology, and in reproductive 
medicine – providing the cells for making stem cell lines – were and still are organized in 
different disciplines, departments, and bound up with different institutional contexts. 
They did not work on a common project, but rather provided tools, material, and 
techniques taken up in research with stem cells or tissue engineering.  
 
 
The descriptor stem cell research gained traction, and the ‘field’ gained reality in the 
sociological pragmatic sense, in the early 2000s when some biologists began to identify 
their professional expertise as stem cell researchers rather than staying aligned with the 
previous disciplinary order. Specialized training programmes in biology departments, 
dedicated journals, teaching books, education courses (Hauskeller, 2004), as well as 
academic conferences and scientific societies are other elements in the 
institutionalization of a stem cell research infrastructure – the International Society of 
Stem Cell Research (ISSCR) was founded in 2002, for instance. Common pragmatic 
interests favoured the organization of a unifying profile under the new umbrella term, 
because it opened up multiple existing governmental and charity routes to funding for 
research, including funds dedicated to treating specific diseases (e.g. cancer, motor 
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neurone disease, heart disease). This also entails that an imperative to translate research 
from bench to bedside shapes scientists’ behaviour and the accounts of their work. The 
directions and pathways in basic research tend to be justified with reference to new 
medical treatments.  
 
 
Many researchers feel that a ‘translational imperative’ (Harrington and Hauskeller, 2014) 
requires them to find ways of justifying their work with its potential societal benefit. 
Other critics of this pressure have argued that the rebranding of basic research as 
working towards regenerative medicine raised unrealistic expectations that cures for a 
broad range of diseases would become imminently available (Kitzinger, 2008; Petersen 
et al., 2017). It has also been argued that the clinical goals were crucial to the rapid 
expansion of stem cell research and laboratories worldwide, and shaped the development 
of standards and methods of experimentation and explanation (Fagan, 2013, 234). 
Whether this is a less diffuse bond between diversely organized and oriented research 
teams across the world has also to be put into question. The orientation towards future 
clinical utility, whilst shared among stem cell researchers, is not something that 
necessarily fosters a sense of community among them. The translational imperative 
affects all basic life science research. Stem cell research competes with other approaches 
in genomics, nano-medicine, and so forth, for funding – and also for the attention of 
medical practitioners, whose enthusiasm is needed for the protracted route into the clinic 
via clinical trials or other experimental uses. The possible bio-economic utility and 
patentability of research findings (see the chapters by Beltrame, Molnár-Gábor, and 
Rosemann, in this volume) may increase competition rather than community. Thus it is 
as easy to argue that it dis-incentivizes (self-)critical assessments of the research 
conducted, and that it has led to a deficit in critique, honesty, and transparency. The 
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pressures of delivering timely results have contributed to premature publication of 
laboratory results and some of the many instances of scientific fraud in stem cell research 
(e.g. Kim, 2013). In this volume, Antonakaki presents a recent case study on the 
technical and political aspects of the persistent problems with establishing methods to 
counteract fraud and to verify experimental results.  
 
 
The matrix of disciplines, institutions, interest groups, and individual agents that take an 
interest in stem cell research can be studied as a configuration of multiple points of 
interaction and tension. Different standpoints and research trajectories can be taken to 
examine what stem cell science is in its different configurations of interacting discourses. 
The many empirical axes of study problematize diverse nodes of contention concerning 
concepts, normative tensions, economic aspects, or diverse research pathways. We 
propose adopting an epistemological perspective that sees responsibility for the forms of 
stem cell research that happen and what happens in and with them, lying not only with 
the natural scientific and medical contributions to stem cell research. Ethicists, lawyers 
and policy-makers, economic and industrial agents as well as patients and consumers 
carry responsibility for their contributions to what and how stem cell science happens. In 




4) Contributions and organization of this volume 
 
This book presents original perspectives on the current state of stem cell science from a 
range of disciplines, including philosophy and various social sciences as well as 
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laboratory research. The chapters do not themselves take the matrix perspective or 
question how stem cell research has been defined. They include state-of-the-art accounts 
that detail specific themes such as tensions over epistemology and scientific practices. 
Other chapters analyse cases or uses of stem cell research that illustrate the peculiar 
discrepancies in political aims or moral commitments that shape its societal and scientific 
practices. The practices studied in the stem cell matrix concern private and public 
enterprises, partnerships between them, patient organizations, regulatory authorities, 
scientific concepts, as well as political and academic interests. The disciplinary contexts 
in which the participants work, and their foci of attention and expertise, jointly show a 
matrix of points of interest and contentions in flux. Several chapters reflect on the 
promises of biomedicine to deliver health benefits that attract both investor and patient 
interest in specific situations. Complex bioeconomies have grown around stem cell 
research, driven by the institutions that manage private or public biobanks or industries 
searching for new medical products. The well-studied publicity and transparency of these 
conditions in and around stem cell science make it a good case study to show the 
relevance of the matrix approach for conceptualizing the life sciences. 
 
 
Together the chapters bring out the diversity of the understandings of stem cell research 
in different partaking disciplines and how academic discourses frame issues. A self-
recursive figure becomes apparent through this multitude of perspectives: the current 
stem cell ‘field’ notion depends on putting the cells and those who work with them at the 
centre, and present philosophical epistemology, sociological studies of scientific or 
societal practice, and legal and ethical debates, as gravitating around this object. The 
notion of disruptive technologies has taken hold especially in debates about social media, 
but many practices in biomedicine and routine parts of stem cell research challenge laws, 
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societal conventions, and moral understandings. Patient rights and clinical research 
regulations stand alongside laws and norms about the use of human cells and embryos 
for research. The configuration of viewpoints in a flexible matrix highlights various 
interacting interpretations of what matters about stem cell science. The cells and the 
clinical orientation are only aspects of broader societal dynamics that shape and respond 
to what happens in the biological and medical sciences.  
 
 
The first three chapters investigate societal practices directly related to and affecting the 
research, thereby illustrating how conditions and actions from outside the laboratory 
shape stem cell research. They offer insights from studies of medical markets and 
biobanking industries as well as patenting law. Claire Tanner, Alan Petersen, Casimir 
MacGregor and Megan Munsie present findings from a sociological case study of the X-
Cell-Center in Germany. This case was among their research cited to explore the 
manifold conditions enabling stem cell tourism. They highlight the roles of regulatory 
loopholes, the publicly nurtured problematic belief in the healing power of stem cells, 
low risk perception, and the appealing treatment conditions on offer. In the next chapter 
Lorenzo Beltrame analyses how economic value is produced in new forms of biobanking 
through the commodification of biological materials, the assetization of knowledge and 
technological capacities, and the exploitation of donors. He compares these aspects 
across two case studies, cord blood stem cell banking, and the circulation of hESC lines. 
Fruszina Molnár-Gábor examines limitations on patentability of results from hESC 
research through opening clauses of international and national patent laws. Her analysis 
of how these opening clauses, such as ‘accepted principles of morality’, are interpreted 
through case law at EU- and member state levels reveals how these legal texts draw in 
and refer to extra-legal motivations for limits on patentability. The relationship between 
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legal norms and extra-legal ethical standards is problematized in the end, especially 
concerning questions of the legitimacy of deciding upon morally contested issues by 
incorporating them into positive law.  
 
 
The next three chapters present the social practices in laboratory stem cell research and 
how its internal logic works in relation to its objects, success indicators, and external 
conditions and pressures. Stem cell laboratory scientists present accounts of their 
contemporary research and its objects, a discussion that will be complemented by two 
philosophy of science studies on those issues. Stem cell research is thriving and has 
diversified its techniques and ways of achieving clinical benefits. In order to illustrate 
this expansion and diversification of the stem cell sciencescape, the three chapters by 
laboratory scientists all belong in one sense to the same specific subfield: the study of 
neuronal cells and neurodegenerative disorders. Yet, they present different approaches 
including induced pluripotent stem cells (iPSC) in clinical translation, new methods of 
reprogramming cells in vivo, that is without removing them from the body, and research 
on ‘diseases in a dish’. First Stephanie Sontag and Martin Zenke report on the current 
state and pitfalls of research with iPSC and the prospects for clinical application; they 
also present a brief introduction to the biology and experimental history of stem cell 
research from their point of view. Maryam Ghasemi-Kasman introduces the methods, 
advantages, and challenges of her current research on developing a way of 
reprogramming in vivo glial cells into neurons – changing cells without removing them 
from the organism with the aim of repairing the central nervous system from within. And 
finally Irina Prots, Beate Winner and Jürgen Winkler introduce their ongoing research of 
stem cell-based models of human neurodegenerative diseases with the aim of better 
understanding disease mechanisms and developing new therapeutics. They create stem 
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cell cultures out of cells taken from patients with the respective diseases on the basic 
assumption that the molecular properties of the cell culture in the laboratory correspond 
to those in the cells of an organism with manifest disease symptoms.  
 
 
The reports by laboratory researchers on their objects, objectives, and the state-of-the-art 
understanding of basic phenomena and clinical aspirations are complemented by the two 
following chapters by philosophers of science who aim to clarify the core concept in 
stem cell research. With her minimal stem cell model and its relation to experimental 
practices, Melinda Fagan provides an overview of the background assumptions about 
biological development and discusses epistemological problems, especially the evidential 
constraints of identifying stem cells, in light of recent debates within the philosophy of 
biology. Building on Fagan’s insights, Anja Pichl then gives an explanation of how the 
common understanding of stem cells as clearly identifiable entities with certain intrinsic 
properties can still be influential on both science and society despite being epistemically 
untenable. The problematic societal and scientific effects of reducing complexity to 
retain the unifying narrative are discussed and traced back to two constituents of the 
field: clinical goals and methodological reductionism.  
 
 
The subsequent three chapters revisit stem cell research as social practice from social 
science perspectives highlighting different normativities.  
The chapters present perspectives from science and technology studies, philosophical 
ethics, and social anthropology, each illustrating the potential of reflective cooperation 
among the humanities, empirical social sciences and STS for examining the intersection 
of knowledge practices and norms of truth and ethics. Melpomeni Antonakaki has studied 
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how the scientific community intended to establish the truth and attributed personal 
responsibility for suspected misconduct concerning the so-called STAP (stimulus-
triggered acquisition of pluripotency) technology to create pluripotency in cells. Findings 
from her laboratory ethnography present a detailed account of the creation of scientific 
facts and the establishing of credibility through record keeping and audit practices. The 
roles that social status and hierarchies play, as well as the observation and transparency 
of laboratory practices in reinforcing credibility and trust that are discussed, undercut the 
myths of science developing in ways driven all from within itself and the objectivity of 
data. Investigations of global governance discourses emphasize the fragility of the 
epistemic configuration and the multiple societal domains life science research is 
entangled with in different contexts of societal values and power orders. Ahmet Karakaya 
decentres the stagnant debate in many, predominantly Western, countries about the moral 
status of the human embryo in relation to its use in hESC research. He conducted, and 
reports from, an empirical interview-based study on the ethical positions of Muslim 
scholars in Turkey on research with human embryos and the normative principles to 
which they refer. The predominant position among these interviewees is more liberal and 
expresses greater regard for the well-being of social persons than the contravening 
powerful arguments put forth by, for example, Catholic theologians on this issue (Levada 
and Ladaria, 2008). This highlights the implicit biases created in uncritical hegemonial 
globalized ethics about the normative foci in the moral reasoning of diverse cultures, 
under conditions of moral pluralism. Achim Rosemann shows that particular forms of 
governance can lead to injustices such as exclusion from new forms of business and 
innovation opportunities for researchers and technology producers from low- and 
middle-income countries. Globally distributed rules and regulations, usually designed by 
predominantly Western industrial and scientific institutions, have produced technical and 
ethical standards addressing Western moral themes such as the moral status of the 
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embryo (Beltrame, in this volume; Karakaya, in this volume; Bender et al., 2005). 
Hauskeller argued that these regulations tend to concur with market prerogatives of 
major laboratory equipment producers and the medicines industry that focus biomedical 
research on alleviating suffering from the diseases of the wealthy. Formal policies and 
regulations shape which research is conducted and how, often in unexpected ways that 
contradict the stated moral and legal justifications for said regulation and the stated 
rationales for the public investments that enable the research. Some potential avenues of 
research, such as therapies using autologous bone marrow stem cell grafts, are positively 
disadvantaged in this regulatory set-up, contrary to ethical commitments expressed by 
those regulators (Hauskeller, 2018). The current governance frameworks require that 
those who want to participate in this research must work in high-tech laboratories and 
evidence high standards of scientific as well as administrative expertise. Those assets and 
conditions are unevenly distributed across the globe. Rosemann examines the tensions 
between the management of technology risks and the demands for social justice in 
emerging international governance frameworks for stem cell and gene drive research. 
The social and ethical problems of containing genetic alterations and the risks they pose 
are just one example for the technological closeness of biomedical research domains and 
the challenges of regulating genomic technologies in and beyond stem cell laboratories. 
 
 
The chapters contribute original work to their authors’ respective primary disciplines, 
and in combination point out areas where conflicts arise between their discourses. They 
demarcate intersections that are part of the current stem cell matrix, without representing 
a comprehensive picture – acting as spotlights on diverse and contradictory societal and 
epistemic factors, dynamics, interests, and values that are active in the development of 
stem cell research. The variety of viewpoints and norms they emphasize sheds some light 
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on ethical issues that are easily overlooked because they fall between disciplinary chairs, 
metaphorically speaking. Some also exemplify the case that ethics as an interdisciplinary 
enquiry of explicit and implicit normative assumptions of factual, sociological, 
philosophical, and legal studies is underway at disciplinary cross-sections – and that 
philosophical and STS can contribute critical normative work by concentrating on these.  
 
 
Questioning what the focus of analysis is in order to define one’s referent or – as we have 
seen above, challenge the existence of a clearly defined field of stem cell research – is 
important for situated, self-critical reflection in philosophy and ethics. If we assume that 
science develops of its own accord, philosophy and ethics are commentating outsiders. 
We have argued that this is a false representation of the genealogy and situation of stem 
cell research. The sciences, natural as well as social, have a continually reaffirmed 
function in a society in which knowledge informs complex socio-political negotiations 
and institutions and vice versa. Based on this understanding, philosophers and ethicists 
are part of the producers and of the production process that carves out the niches and 
functions of science in society. Because of the publicly conducted controversies about it 
in the 2000s, stem cell research provides a very effective case study to unpick 
depoliticized linear narratives of scientific development that cover up the complex 
processes that go into the creation of the sciencescape. The matrix of stem cell science 
contains the discourses of ethicists, lawyers, philosophers, clinical and laboratory 
scientists, social scientists, theologians – especially where they affect policy and the 
public understanding of what goes on in scientific research. It also considers the 
influences from non-academic participants, such as publics and the industries that 





This volume elucidates some of the constitution conditions of stem cell research to open 
up dialogues with scholars from all disciplines interested in furthering the understanding 
of the contemporary life sciences. On that basis a critical understanding of stem cell 
research as a social practice can emerge, that highlights the historic, societal, economic, 
cultural, ideological, epistemic, and material conditions and thus the changeability of the 
factors shaping science pathways. Drawing on and including concepts from STS the 
matrix approach points philosophy of science and ethics towards ways of rethinking the 
science and society intersection and reshaping it conceptually. Unpacking some of the 
black boxes concerning constituents of the field of stem cell research raises questions 
about what societal goals diverse social practices including the life sciences aim to 
achieve. In that sense, we collated this volume to present the state of the art in reflecting 
on stem cell research that might contribute to collectively reorienting such work towards 




This matrix approach, as conveyed through the format of this book, evolved from the editors’ 
continuing discussions following the international summer school ‘Pluripotent Stem Cells: 
Scientific Practice, ethical, legal, and social commentary’ in late 2015. Several of the 
contributors to this volume presented at the event whereas others were invited to contribute later, 
and we are grateful to all the authors for their willingness to provide original articles on their 
special research projects in the stem cell matrix.  
We also express our gratitude to the institutions who supported us through this process, among 
them first and foremost the German Federal Ministry of Education and Research (BMBF) who 
awarded Arne Manzeschke generous funding for organizing the summer school in Bavaria and 
the project’s public closing event in April 2017, as well as for the edition of this volume in 
English (funding code FKZ: 01GP1482). The Bavarian research network on human induced 
pluripotent stem cells, ForIPS, funded by the Bavarian State Ministry of Science and the Arts 
(funding code D2-F2412.26), in which Arne and Anja were active between 2014 and 2017 also 
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supported the project, and so did the University of Exeter with top-up funding for copy-editing. 
We further thank the conscientious peer reviewers who supported the development of the 
chapters and, last but not least, we endorse and thank Dr. Peter Hughes for his thoughtful editing, 
close attention to detail, and timely delivery of copyedited texts – whilst concurrently completing 
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